JPWO2023239290A5 - - Google Patents
Info
- Publication number
- JPWO2023239290A5 JPWO2023239290A5 JP2024572034A JP2024572034A JPWO2023239290A5 JP WO2023239290 A5 JPWO2023239290 A5 JP WO2023239290A5 JP 2024572034 A JP2024572034 A JP 2024572034A JP 2024572034 A JP2024572034 A JP 2024572034A JP WO2023239290 A5 JPWO2023239290 A5 JP WO2023239290A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- tcr
- amino acid
- variable region
- fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210626787.7 | 2022-06-05 | ||
| CN202210626787.7A CN117209588A (zh) | 2022-06-05 | 2022-06-05 | 乙肝表面抗原特异性t细胞受体及其用途 |
| PCT/SG2022/050892 WO2023239290A1 (en) | 2022-06-05 | 2022-12-08 | Hbv surface antigen specific t cell receptors and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025519475A JP2025519475A (ja) | 2025-06-26 |
| JPWO2023239290A5 true JPWO2023239290A5 (https=) | 2025-12-11 |
| JP2025519475A5 JP2025519475A5 (https=) | 2025-12-11 |
Family
ID=89039487
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024572034A Pending JP2025519475A (ja) | 2022-06-05 | 2022-12-08 | Ｈｂｖ表面抗原特異的ｔ細胞受容体およびその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20260021140A1 (https=) |
| EP (1) | EP4536695A1 (https=) |
| JP (1) | JP2025519475A (https=) |
| KR (1) | KR20250031233A (https=) |
| CN (1) | CN117209588A (https=) |
| AU (1) | AU2022462612A1 (https=) |
| CA (1) | CA3258313A1 (https=) |
| IL (1) | IL317429A (https=) |
| WO (1) | WO2023239290A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11214603B2 (en) * | 2016-04-27 | 2022-01-04 | The Regents Of The University Of Michigan | C3D cellular and acellular vaccines for the prevention and treatment of cancer |
| CN117624340B (zh) * | 2024-01-23 | 2024-04-30 | 北京臻知医学科技有限责任公司 | 识别人乙型肝炎病毒（hbv）抗原的t细胞受体（tcr）及其用途 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107827959B (zh) * | 2017-11-09 | 2018-10-30 | 杭州续缓生物科技有限公司 | 识别乙肝病毒(hbv)表面抗原s183-91表位的tcr及其用途 |
-
2022
- 2022-06-05 CN CN202210626787.7A patent/CN117209588A/zh active Pending
- 2022-12-08 WO PCT/SG2022/050892 patent/WO2023239290A1/en not_active Ceased
- 2022-12-08 KR KR1020257000133A patent/KR20250031233A/ko active Pending
- 2022-12-08 AU AU2022462612A patent/AU2022462612A1/en active Pending
- 2022-12-08 JP JP2024572034A patent/JP2025519475A/ja active Pending
- 2022-12-08 EP EP22945970.6A patent/EP4536695A1/en active Pending
- 2022-12-08 US US18/871,858 patent/US20260021140A1/en active Pending
- 2022-12-08 CA CA3258313A patent/CA3258313A1/en active Pending
- 2022-12-08 IL IL317429A patent/IL317429A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022115876A5 (https=) | ||
| JP2023061927A5 (https=) | ||
| JP2021524267A5 (https=) | ||
| JP2023103455A5 (https=) | ||
| JP2025184979A5 (https=) | ||
| JP2023040169A5 (https=) | ||
| JP2008507298A5 (https=) | ||
| JP2020509737A5 (https=) | ||
| JP2021531834A5 (https=) | ||
| JP2021512613A5 (https=) | ||
| JPWO2020059847A5 (https=) | ||
| JP2023086734A5 (https=) | ||
| JPWO2020011976A5 (https=) | ||
| JPWO2021016724A5 (https=) | ||
| JPWO2021116182A5 (https=) | ||
| JP2022079486A5 (https=) | ||
| JPWO2020216697A5 (https=) | ||
| JP2009540842A5 (https=) | ||
| JPWO2023239290A5 (https=) | ||
| WO2023143445A1 (zh) | 用于治疗hbv感染及相关疾病的表位肽及抗体 | |
| JP2019527238A (ja) | 薬物送達のための抗体融合タンパク質 | |
| JPWO2022129560A5 (https=) | ||
| CN111234015A (zh) | 用于延长药物半衰期的抗体、其融合蛋白和应用 | |
| JPWO2020024915A5 (https=) | ||
| WO2023196913A2 (en) | Methods of treating ankylosing spondylitis |